Earnings News

Latest earnings news and updates for US-listed public companies.

📣 Get earnings alerts and analysis

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quar...

What is the implied valuation impact of this earnings release on the stock’s price‑to‑sales, price‑to‑earnings, and other valuation multiples? Are there any risks or uncertainties highlighted in the release (e.g., supply‑chain constraints, regulatory changes, or competitive pressures) that could impact the stock? How did the company's guidance and outlook affect analyst sentiment and target price revisions?
Symbol: TWST
24 days ago
Read more businesswire

CommScope Reports Second Quarter 2025 Results

CLAREMONT, N.C.--(BUSINESS WIRE)-- #InvestorRelations--CommScope Holding Company, Inc. (NASDAQ: COMM), a global leader in network connectivity solutions, reported results for quarter ended June 30,...

How does CommScope’s performance position it against competitive pressure from legacy and emerging optical‑connectivity providers? Is there any impact from recent mergers, acquisitions, or divestitures on reported results? What macro‑economic factors (e.g., semiconductor shortage, supply‑chain disruptions) are highlighted as risks?
Symbol: COMM
24 days ago
Read more businesswire

Precision BioSciences to Report Second Quarter 2025 Results on August 7, 2025

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUSÂź platform to develop in vivo gene editing ther...

How does Precision BioSciences’ valuation metrics (e.g., EV/Revenue, P/E, price/cash‑burn) compare to peer companies in the gene‑editing space? What are the potential short‑term catalysts (e.g., data releases, FDA meetings) that could move the stock after the August 7 announcement? Are there any material changes to the capital structure (e.g., stock issuances, debt financings, share buy‑backs) disclosed in the update?
Symbol: DTIL
24 days ago
Read more businesswire

Bruker Reports Second Quarter 2025 Financial Results

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2025. Frank H. La...

What upside or downside scenarios exist for Bruker if the tariff environment improves or worsens? What is the anticipated short‑term impact on Bruker’s stock price based on the missed expectations and current sentiment? What inventory trends are emerging in the US academic market and how might they impact future shipments?
Symbol: BRKR
24 days ago
Read more businesswire

Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York S...

What technical or short‑term trading opportunities could arise from the earnings release timing and post‑release price action? Are there any risks or headwinds highlighted by management (e.g., regulatory scrutiny, competitive pressure) that could affect OMI's long‑term growth trajectory? Will the conference call include any commentary on capital‑allocation plans, such as debt repayment, share repurchases, or M&A activity, and what are the implications for shareholders?
Symbol: OMI
24 days ago
Read more businesswire

IDEXX Laboratories Announces Second Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. “Our innovation-driven strategy del...

What are the long‑term strategic effects of this innovation‑driven strategy on IDEXX's competitive positioning? Are there any operational or supply‑chain constraints that could temper the growth momentum depicted in the release? How might this results release affect institutional and retail inflows into IDXX stock?
Symbol: IDXX
24 days ago
Read more businesswire

Emerald Reports Second Quarter 2025 Financial Results

NEW YORK--(BUSINESS WIRE)--Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), America’s largest producer of trade shows and their associated conferences, content and commerce, today re...

Are there any changes in operating expenses or margins that could influence the stock's momentum? What guidance is management providing for 2025 regarding revenue growth and margin expansion? How does EEX's Q2 2025 performance compare to peers in the trade show and conference industry?
Symbol: EEX
24 days ago
Read more businesswire